June 25, 2019

FDA: Class I recall of Hudson RCI Sheridan, Sheridan Endotracheal Tubes

By: Judy Mathias

Editor’s Note

The Food & Drug Administration on June 21 identified the recall by Teleflex Medical (Wayne, Pennsylvania) of the Hudson RCI Sheridan and Sheridan Endotracheal Tubes as Class I, the most serious.

The recall was initiated because of the risk of the Sheridan connector disconnecting from the breathing circuit.

The company has received 179 complaints with 192 occurrences related to the disconnection, including two deaths and one injury.

Distribution dates were October 2016 to May 2019.

Break Loose From OR Holds: Confronting Throughput Challenges in Your PACU
You may also be interested in this session at the OR Manager Conference

After this session you'll be able to: Identify key areas of patient flow that can be redirected to enhance throughput and minimize holds. Discuss whether the OR should be on…

Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat